…Teva might have a stake there due to the Ivax acquisition…
Duly noted. I’d be interested in any further details on Teva’s stake in the program; the latest 20-F filing says essentially the same thing that you posted.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”